Schott has legally established a stand-alone company for its pharma business to advance its growth strategy. As part of the carve-out, the pharma business will operate under the new name Schott Pharma AG & Co. KGaA.   “By creating a separate legal entity for our pharma business, we are generating new opportunities to expedite our profitable growth,” says Schott CEO Dr. Frank Heinricht.   “At the same time, this step enables us to explore new financing options, including...